Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...
Innogen, a Shanghai-based medical technology company, announced that its independently developed, human-derived, ...
But the results add to evidence from animal studies and reports that people are finding drugs like Ozempic and Wegovy helpful ...
Women prescribed a GLP-1 receptor agonist up to 2 years before conception were less likely to develop hypertensive disorders ...
Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.
A new study has raised serious concerns about Ozempic, the weight-loss drug taking the world by storm. While it has ...
The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...
The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...
Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...